Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Linde
LIN
|
$588M |
| 2 |
Apple
AAPL
|
$574M |
| 3 |
Illumina
ILMN
|
$398M |
| 4 |
Monster Beverage
MNST
|
$396M |
| 5 |
argenx
ARGX
|
$306M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$600M |
| 2 |
AbbVie
ABBV
|
$323M |
| 3 |
Sherwin-Williams
SHW
|
$309M |
| 4 |
Atlassian
TEAM
|
$250M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$241M |
Sector Composition
| 1 | Technology | 31.85% |
| 2 | Healthcare | 19.69% |
| 3 | Industrials | 10.43% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
TE Connectivity
TEL
$61B
| $1B | 0.66% | 7,660,450 -1,021,545 | -12% | -$134M |
|
27
Ferguson
FERG
$46.4B
| $939M | 0.62% | 7,054,439 +461,565 | +7% | +$61.4M |
|
28
KLA
KLAC
$115B
| $909M | 0.6% | 2,277,811 -135,182 | -6% | -$54M |
|
29
Abbott
ABT
$231B
| $904M | 0.6% | 8,925,749 +1,015,840 | +13% | +$103M |
|
30
CoStar Group
CSGP
$37.9B
| $901M | 0.59% | 13,081,306 +82,995 | +0.6% | +$5.71M |
|
31
ASML
ASML
$292B
| $894M | 0.59% | 1,313,142 -231,078 | -15% | -$157M |
|
32
Thermo Fisher Scientific
TMO
$186B
| $855M | 0.56% | 1,483,053 -60,823 | -4% | -$35.1M |
|
33
SS&C Technologies
SSNC
$21.7B
| $838M | 0.55% | 14,837,078 -136,745 | -0.9% | -$7.72M |
|
34
Progressive
PGR
$145B
| $830M | 0.55% | 5,805,203 +118,566 | +2% | +$17M |
|
35
Danaher
DHR
$147B
| $817M | 0.54% | 3,241,751 -194,969 | -6% | -$49.1M |
|
36
McDonald's
MCD
$224B
| $803M | 0.53% | 2,872,815 +34,677 | +1% | +$9.7M |
|
|
CTLT
37
DELISTED
CATALENT, INC.
CTLT
| $790M | 0.52% | 12,016,486 +3,800,244 | +46% | +$250M |
|
38
Howmet Aerospace
HWM
$70.2B
| $788M | 0.52% | 18,596,413 -110,530 | -0.6% | -$4.68M |
|
39
Teleflex
TFX
$5.59B
| $785M | 0.52% | 3,099,942 +955,929 | +45% | +$242M |
|
|
40
Illumina
ILMN
$15.8B
| $780M | 0.51% | 3,354,218 +1,711,163 | +104% | +$398M |
|
|
41
Meta Platforms (Facebook)
META
$1.86T
| $771M | 0.51% | 3,637,122 -2,828,724 | -44% | -$600M |
|
42
Accenture
ACN
$162B
| $767M | 0.51% | 2,682,300 +263,366 | +11% | +$75.3M |
|
|
43
Atlassian
TEAM
$46.6B
| $731M | 0.48% | 4,272,293 -1,461,356 | -25% | -$250M |
|
44
T-Mobile US
TMUS
$284B
| $731M | 0.48% | 5,044,998 +119,609 | +2% | +$17.3M |
|
45
WEX
WEX
$5.87B
| $707M | 0.47% | 3,842,850 +15,664 | +0.4% | +$2.88M |
|
46
Amdocs
DOX
$9.41B
| $702M | 0.46% | 7,307,318 +307,868 | +4% | +$29.6M |
|
47
Sarepta Therapeutics
SRPT
$1.78B
| $677M | 0.45% | 4,908,204 -1,119,812 | -19% | -$154M |
|
|
48
Linde
LIN
$224B
| $675M | 0.44% | 1,898,173 +1,653,581 | +676% | +$588M |
|
49
LPL Financial
LPLA
$29.2B
| $669M | 0.44% | 3,305,996 -156,828 | -5% | -$31.7M |
|
|
50
argenx
ARGX
$43.6B
| $669M | 0.44% | 1,794,810 +820,090 | +84% | +$306M |
|